NCT04559607 2023-12-18
TACE Combined With Camrelizumab and Apatinib in Intermediate and Advanced Hepatocelluar Carcinoma
Zhongda Hospital
Phase NA Unknown
Clinical Trials
12 trialsNCT05653817 2022-12-16
Advanced or Metastatic Cholangiocarcinoma
First Affiliated Hospital Xi'an Jiaotong University
Phase NA Unknown
NCT05380986 2022-05-19
Camrelizumab Combined With Apatinib Mesylate
Henan Cancer Hospital
Phase NA Unknown
NCT04950400 2021-07-06
A Study of Camrelizumab Combined With Chemotherapy Sequential Camrelizumab Combined With Apatinib Treatment of Advanced NSCLC
Beijing Chest Hospital
Phase NA Unknown
NCT04507750 2020-09-21
Camrelizumab Combined With Apatinib in the Treatment of Epithelial Ovarian Cancer
Qianfoshan Hospital
Phase NA Unknown
NCT04174339 2019-11-22
PD-1 Antibody(SHR-1210) Plus Apatinib Combined With POF in Advanced Gastric Cancer
Fujian Cancer Hospital
Phase NA Unknown
NCT03671265 2019-01-09
Combination of Chemotherapy Plus RT and SHR-1210 to Treat Patients With ESCC
Tianjin Medical University Cancer Institute and Hospital
Phase NA Unknown
NCT03722875 2018-12-19
SHR-1210 Plus Apatinib in Patients With Hepatocellular Carcinoma After Surgery
Shanghai Zhongshan Hospital
Phase NA Unknown
NCT03398122 2018-01-12
HCC
Tianjin Medical University Cancer Institute and Hospital
Phase NA Unknown
NCT03255811 2017-08-21
Clinical Study on Treatment of Apatinib Mesylate in First-line Maintenance of Advanced Gastric Cancer
Guangdong Provincial People's Hospital
Phase NA Unknown
NCT03066557 2017-02-28
Study of the Combination of TACE With Apatinib in Patients With Hepatocellular Carcinoma
Jiangsu Cancer Institute & Hospital
Phase NA Unknown
NCT03029013 2017-01-23
Apatinib and Chemotherapy Sequential Treatment With Cervical Cancer
Third Military Medical University
Phase NA Unknown